Skip to content
healthcare.dev

VERAPAMIL HYDROCHLORIDE

NDC 71209-047, verapamil hydrochloride, tablet, extended release, from Cadila Pharmaceuticals Limited.

Product NDC
71209-047
Status
Listed
Labeler
Cadila Pharmaceuticals Limited
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA206173
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71209-047 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • VERAPAMIL HYDROCHLORIDE180 mg/1

Pharmacologic classes

Calcium Channel Antagonists [MoA]; Calcium Channel Blocker [EPC]; Cytochrome P450 3A Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]

Package NDCNDC-11Package
71209-047-0571209004705100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71209-047-05)
71209-047-1071209004710500 TABLET, EXTENDED RELEASE in 1 BOTTLE (71209-047-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5501208c-aa2b-47aa-89f7-87f4d4a73fd0

Use it

Look up 71209-047 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71209-047 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71209-047. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.